These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone. Keidar S, Kaplan M, Pavlotzky E, Coleman R, Hayek T, Hamoud S, Aviram M. Circulation; 2004 May 11; 109(18):2213-20. PubMed ID: 15123520 [Abstract] [Full Text] [Related]
3. Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice. Keidar S, Hayek T, Kaplan M, Pavlotzky E, Hamoud S, Coleman R, Aviram M. J Cardiovasc Pharmacol; 2003 Jun 11; 41(6):955-63. PubMed ID: 12775976 [Abstract] [Full Text] [Related]
4. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Rozenberg O, Rosenblat M, Coleman R, Shih DM, Aviram M. Free Radic Biol Med; 2003 Mar 15; 34(6):774-84. PubMed ID: 12633754 [Abstract] [Full Text] [Related]
5. Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice. Rozenberg O, Shih DM, Aviram M. Atherosclerosis; 2005 Jul 15; 181(1):9-18. PubMed ID: 15939049 [Abstract] [Full Text] [Related]
6. Omapatrilat decreased macrophage oxidative status and atherosclerosis progression in atherosclerotic apolipoprotein E-deficient mice. Hayek T, Hamoud S, Keidar S, Pavlotzky E, Coleman R, Aviram M, Kaplan M. J Cardiovasc Pharmacol; 2004 Jan 15; 43(1):140-7. PubMed ID: 14668580 [Abstract] [Full Text] [Related]
7. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism. Fuhrman B, Khateeb J, Shiner M, Nitzan O, Karry R, Volkova N, Aviram M. Arterioscler Thromb Vasc Biol; 2008 Jul 15; 28(7):1361-7. PubMed ID: 18436804 [Abstract] [Full Text] [Related]
8. The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice. Hayek T, Attias J, Coleman R, Brodsky S, Smith J, Breslow JL, Keidar S. Cardiovasc Res; 1999 Dec 15; 44(3):579-87. PubMed ID: 10690290 [Abstract] [Full Text] [Related]
9. Oxidative stress increases the expression of the angiotensin-II receptor type 1 in mouse peritoneal macrophages. Keidar S, Heinrich R, Kaplan M, Aviram M. J Renin Angiotensin Aldosterone Syst; 2002 Mar 15; 3(1):24-30. PubMed ID: 11984744 [Abstract] [Full Text] [Related]
13. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, Stengel D, Ninio E, Navab M, Mackness B, Mackness M, Holvoet P. Circulation; 2003 Apr 01; 107(12):1640-6. PubMed ID: 12668499 [Abstract] [Full Text] [Related]
14. Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis. Hayek T, Kaplan M, Raz A, Keidar S, Coleman R, Aviram M. Atherosclerosis; 2002 Mar 01; 161(1):65-74. PubMed ID: 11882318 [Abstract] [Full Text] [Related]
15. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. J Clin Invest; 1998 Apr 15; 101(8):1581-90. PubMed ID: 9541487 [Abstract] [Full Text] [Related]
19. Anti-oxidant and anti-atherogenic properties of liposomal glutathione: studies in vitro, and in the atherosclerotic apolipoprotein E-deficient mice. Rosenblat M, Volkova N, Coleman R, Aviram M. Atherosclerosis; 2007 Dec 15; 195(2):e61-8. PubMed ID: 17588583 [Abstract] [Full Text] [Related]